Obsessive-compulsive disorder (OCD) is the tenth most disabling medical condition worldwide. Twin and family studies implicate a genetic etiology for this disorder, although specific genes have yet to be identified. Here, we present the first large-scale model-free linkage analysis of both extended and nuclear families using both 'broad' (definite and probable diagnoses) and 'narrow' (definite only) definitions of OCD. We conducted a genome-scan analysis of 219 families collected as part of the OCD Collaborative Genetics Study. Suggestive linkage signals were revealed by multipoint analysis on chromosomes 3q27-28 (P = 0.0003), 6q (P = 0.003), 7p (P = 0.001), 1q (P = 0.003), and 15q (P = 0.006). Using the 'broad' OCD definition, we observed the strongest evidence for linkage on chromosome 3q27-28. The maximum overall Kong and Cox LOD all score (2.67) occurred at D3S1262 and D3S2398, and simulation based P-values for these two signals were 0.0003 and 0.0004, respectively, although for both signals, the simulation-based genome-wide significance levels were 0.055. Covariate-linkage analyses implicated a possible role of gene(s) on chromosome 1 in increasing the risk for an earlier onset form of OCD. We are currently pursuing fine mapping in the five regions giving suggestive signals, with a particular focus on 3q27-28. Given probable etiologic heterogeneity in OCD, mapping gene(s) involved in the disorder may be enhanced by replication studies, large-scale family-based linkage studies, and the application of novel statistical methods.
Introduction
Obsessive-compulsive disorder (OCD) (MIM 164230) is a psychiatric condition characterized by intrusive, senseless thoughts and impulses (obsessions) and repetitive, intentional behaviors (compulsions). The disorder affects approximately 1-3% of the US population 1 and is among the 10 most disabling medical conditions in the world. 2 Although once thought to be primarily psychological in origin, there is now compelling evidence from twin and family studies that OCD has a genetic basis. A twin study found concordance rates of 87% in monozygotic twins and 47% in dizygotic twins. 3 Results from family studies indicate an increased aggregation of the disorder among relatives of adult 4, 5 and child and adolescent OCD probands. [6] [7] [8] Further, results from a complex segregation analysis support a Mendelian dominant or codominant model for OCD. 9 Other investigators have also reported evidence for major genes underlying OCD, 10, 11 but a precise pattern of inheritance could not be established, suggesting that OCD is genetically heterogeneous.
The aim of the current study was to identify linkage regions through a genomewide scan, at an approximate density of 9 cM, in 219 OCD families collected in the US.
Methods

Sample collection
The OCD Collaborative Genetics Study (OCGS), which commenced in 2001, is an ongoing, NIMHfunded collaboration among investigators at six sites in the US (Brown University, Columbia University, Johns Hopkins University, Massachusetts General Hospital, University of California at Los Angeles, and the National Institute of Mental Health). The methods are described in detail elsewhere 12 and summarized below.
The OCGS ascertained families with OCD-affected sibling pairs, and extended these when possible through affected first-and second-degree relatives; in addition, two sites also collected other pedigrees with multiple-affected relatives when these were available. Subjects were recruited into the study from outpatient and inpatient clinics, referrals from clinicians in the community, web sites, media advertisements, self-help groups, and annual conventions of the Obsessive Compulsive Foundation.
To be considered affected, a subject had to meet Diagnostic and Statistical Manual (DSM)-IV OCD diagnostic criteria at any time in his/her life. 13 Probands were included if, in addition to meeting DSM-IV criteria, their first onset of obsessions and/or compulsions occurred before 18 years of age. Probands with schizophrenia, severe mental retardation, Tourette disorder, or secondary OCD (OCD occurring exclusively in the context of depression) were excluded. Subjects had to be at least 7 years old to participate in the study. Written, informed consent (or assent, for children) to study procedures was obtained before the clinical interview. The protocol was approved by the institutional review board at each site.
Diagnostic assessments were conducted by psychiatrists or PhD-level psychologists experienced with clinical evaluations using the OCGS assessment package, modified and developed for the study, as a semistructured format for the evaluation of psychopathology. The OCD section was adapted from the schedule for affective disorders and schizophrenialifetime anxiety version (SADS-LA-R) 14 and included detailed screening questions; the Yale Brown obsessive compulsive scale (YBOCS) and symptom checklist, 15 and additional questions on onset, course, and treatment of symptoms. A similar section was developed for assessing tics, Tourette disorder, and other tic disorders. The structured clinical interview for DSM-IV (SCID) 16 was used for assessing other major Axis I diagnoses, and a semistructured assessment protocol was used for additional diagnoses of interest. In adults, items from the structured instrument for the diagnosis of DSM-IV personality disorders 17 was used to assess the presence of personality disorders. The Family Informant Schedule and Criteria 18 was used to obtain additional information about each subject from a knowledgeable informant. For subjects who had received psychiatric treatment, consent was obtained to review relevant medical records and to contact treatment providers, if such information was deemed useful for making diagnoses. Examiners completed a narrative formulation for each case.
The JHU diagnostic assignment checklist was used to collate all the clinical information from a variety of sources (the semistructured direct interview, case formulation, informant interview, and medical records). The checklist presents logical algorithms with specified rules, allowing assignment of definite, probable, absent, or unknown for each disorder. All psychiatric diagnoses were made according to strict DSM-IV criteria. 13 At each site, each case was reviewed independently by two expert diagnosticians who reviewed all case materials. Final diagnoses were assigned by diagnosticians at Johns Hopkins University. If all criteria required for having the disorder were met, then a 'definite' diagnosis was given. If any required criterion was clearly not met, then the diagnosis was considered 'absent'. If it seemed likely that the subject had the diagnosis, but the diagnosticians could not be certain of a given criterion (required for definite diagnosis), then the diagnosis was made at the 'probable' level. If the diagnosticians could not be sure of the presence or absence of a given diagnosis, then that diagnosis was recorded as 'unknown'.
Blood samples were collected from all affected probands, their parents, and their affected relatives. If available, blood samples from unaffected relatives were also collected to help determine phase used for computing identity by descent (IBD) sharing probabilities.
Molecular genotyping
Genotyping was performed at the Center for Inherited Disease Research (CIDR) using a modification of the CHLC version 10 marker set (386 microsatellite markers; average spacing of 9 cM; and average heterozygosity of 0.76). For the whole genome scan, 1056 individuals were genotyped including 1008 study samples and 48 duplicate quality control samples. Allele calls were reviewed by two technicians, blind to family structure and phenotype. Binning of all allele sizes for each marker was performed using the FASTCLUS procedure in SAS. Calls falling outside of bins and Mendelian inconsistencies (identified using GAS 19 ) were reviewed for laboratory error. The overall missing data rate was 3.56% (15 050 missing genotypes/423 306 genotypes) and the inconsistency rate was 0.48% (1948 events/ 408 240 study genotypes). Additional details related to genotyping methodology can be found at www.cidr.jhmi.edu.
Family relationships were analyzed using RE-LCHECK. 20 Misspecified relationships were corrected or removed if there was insufficient information to determine the true relationship. In addition, PED-CHECK was used for more complicated genotyping error checking for each individual in the data set. 21 Those genotypes with a posterior probability of being incorrect of greater than 75% were removed from the analysis, as recommended by Douglas et al. 22 In addition, we also used the Merlin program 23 to check for Mendelian inconsistencies and to identify genotypes associated with an excessive number of observed recombinations. Marker allele frequencies were computed using data from one individual randomly chosen from each pedigree.
Statistical methods
Multipoint allele-sharing methods were used to assess evidence for linkage by testing the null hypothesis given d = 0, where d is the extent deviated from expected IBD sharing. 24 Using Merlin version 0.10.2, 23 we computed both the Kong and Cox logarithm of odds (LOD) all (KAC all ) and the Kong and Cox LOD pairs (KAC pairs ) statistics. In general, the score 'all' provides more information when relative pairs included in a data set are not independent and performs very well for most simulated genetic models evaluated by Sengul et al. 25 On the other hand, Davis and Weeks 26 commented that the score 'pairs' performs better than 'all' when the disease allele is likely to have entered the pedigree more than once (one scenario is when a recessive disease has a fairly common allele).
Empirical P-values were estimated by simulation under the null hypothesis, using 10 000 replicates with Merlin. In each simulation, the original phenotypes were used and a new data set, with the same allele frequencies, marker order, genetic distances between markers, as well as missing-data patterns, was generated. Therefore, 'significant signals' obtained through simulation are chance findings. Intuitively, when the simulation-derived P-values are lower, the probability of observing a false positive KAC LOD score is smaller.
Further, covariate based analysis was also performed for chromosomes with significant linkage signals. Olson 27 developed a unified approach for the detection of linkage that incorporates covariate data directly by using a general conditional logistic regression model. In this model, the likelihood ratio of IBD allele sharing probabilities (f r,i ) for an affected relative pair (r) is computed given the information on IBD sharing: LR ¼ P i¼0;1;2 l ifr;i = P i¼0;1;2 l i f r;i . The relative risk l i for a given relative pair sharing (i) alleles IBD is re-parameterized by a conditional logistic regression model allowing for K covariates, where
The main advantage of directly incorporating the covariates into the likelihood ratio test is that it allows for the simultaneous estimation of both the linkage effect and the covariate effects, and therefore, allows for covariate-related locus heterogeneity. Using permutation, we also calculated empirical P-values for the significant LOD scores reported by LODPAL when age of onset was included as a covariate.
Results
Two phenotypic definitions were used. The 'narrow' definition was limited to individuals with a diagnosis of 'definite' OCD, while the broad definition included 'definite' and 'probable' OCD cases. For the 'narrow' phenotype, 193 families were analyzed and, for the 'broad' phenotype, 219 families were analyzed. 'Probable OCD' was coded as 'unknown' for the narrow phenotype and as 'affected' for the broad phenotype. This stringent definition resulted in more 'unknown' individuals in the 'narrow' families than the 'broad' families ( Table 1) .
The single point linkage results (data not shown) and multipoint analysis are concordant with respect to the locations of maximum KAC LOD scores. The results from the multipoint genome scan are presented in Figure 1 (Àlog (P) for 'broad OCD' are shown as a blue line and those for 'narrow OCD' are shown as a black line). More detailed comparisons of Pvalues obtained under the two phenotypes computed by two different statistics are given in Table 2 .
Using a cutoff of 0.01, the multipoint nonparametric analyses found suggestive linkage signals on chromosome 1 (KAC pairs = 1.61, P-value = 0.003 with the broad phenotype at D1S1677) and chromosome 3 (KAC all = 2.67, P-value = 0.0002 with the narrow phenotype at D3S1262, and KAC all = 2.67, P-value = 0.0002 with the broad phenotype at D3S2398). On chromosome 6, the lowest P-value was obtained with the broad phenotype (KAC all = 1.58, P-value = 0.003) at marker D6S1027. On chromosome 7, signals with P-values < 0.01 were observed in a region of 70 cM (from D7S3056-D7S3046) with the broad phenotype, and the most significant P-values were Table 2 .
Owing to computational burden, 10 000 replicates were simulated for those signals with P-values less than 0.01 by simulating markers at the same locations with the same allele frequencies using Merlin. The simulation-derived P-values for all relevant multipoint P-values are shown in Table 3 . For the signal at D3S1262, on chromosome 3, we also calculated the genomewide significance level (0.055) based on simulations using an approach advocated by Kruglyak and Daly. 28, 29 One pedigree with 14 genotyped individuals and 10 affected individuals (nine definite and one probable) had a Kong and Cox LOD all of 1.20. However, the peak score for that pedigree was obtained at 161 cM (near D3S1744) on chromosome 3q24, a different location from where the highest overall LOD score occurred (201-209 cM on chromosome 3q27-28). When we dropped this pedigree from the whole sample, and repeated the multiple analyses on chromosome 3, the results did not change significantly.
Familial correlation analysis and covariate-based linkage analysis
It has been well documented that age of onset can be used to identify the source of genetic heterogeneity using covariate-based linkage analysis. 30 To further justify the rationale for including age of onset as a covariate in linkage analysis, we first present the familial correlation analysis using age of onset as an outcome variable. Familial correlations in 219 families were estimated using the FCOR2 procedure implemented in SAGE 5.0.
31 Correlations for firstdegree relative-pairs were estimated as 0.28 in brother-brother pairs, 0.18 in brother-sister pairs and 0.15 in sister-sister pairs, thus supporting some level of familiality for age of onset in OCD families.
Using age of onset as a covariate, we then performed covariate-based linkage analysis using LODPAL (SAGE 5.0). Results are presented in Figure  2 . We performed analyses with or without age of onset as a covariate for chromosomes 1,3,6,7, and 15. Further, to determine empirical P-values for each LOD score computed by LODPAL, with or without the covariate, we fixed the affection status for each individual and then permuted the covariate values among the affected relative pairs, after breaking the pedigree structure (1000 permutations were performed). The empirical P-value for that LOD score was the number of times that we observed a given LOD score across the chromosome out of 1000 replicates when we analyzed each replicate with LODPAL (Peter Holmans, personal communication).
For instance, the LOD score was 2.94 at D1S1679 (empirical P-value = 0.001). On chromosome 7p, there is a clear difference between the LOD scores obtained at D7S1802 with or without the covariate. The maximum LOD score of 2.00 was obtained at 114 cM (empirical P-value = 0.01), and this signal was not detected in the original linkage analysis. Although a LOD score of 1.94 was obtained at D15S503 when age of onset was included in the analysis, the empirical P-value was 0.178. Therefore, this observation was not considered a statistically significant finding for heterogeneity of age of onset. The LOD scores obtained on chromosome 3q and 6q did not differ significantly with or without these covariates. Although the LODPAL analysis results indicated the possibility that power to detect linkage is greater when age of onset is considered in the analysis, this statistical method cannot resolve whether it is the families with younger or later onset that contribute disproportionately to the linkage information on chromosomes 1 and 7. Thus, we performed a stratified analysis using proband's age of onset where 7 years is the cut point (the median age of onset among the probands) in Merlin. The KAC LOD score was 2.08 at D1S1679 in families with earlier age of onset and the KAC LOD score was 1.25 at D7S817 on chromosome 7 in families with later age of onset.
Discussion
Our genome scan of 219 families represents the first large-scale genome scan searching for genetic loci that predispose individuals to OCD. The strongest signals were observed on chromosome 3 at D3S1262 with the 'narrow' phenotype and the 'all' statistic, and at D3S2398 with the 'broad' phenotype and the 'all' statistic. The KAC LOD score was 2.67 for both D3S1262 and D3S2398, respectively (analytical Figure 1 Multipoint analysis results. In Figure 1 , the black line represents the narrow OCD definition and the blue line represents the broad OCD definition. Àlog(P) was calculated from P-values generated by Merlin. Map distance presented is Kosambi. P-value = 0.0002). The chance of observing a KAC LOD score of 2.67 based on the simulation of 10 000 replicates under the null hypothesis was 0.0003 at 201 cM on chr3q27 and 0.0004 at 209 cM on chr3q28.
The analytical P-values and simulated P-values appear to be similar. Further, genomewide significance level for both signals was 0.055, which suggests the finding on chromosome 3 is relatively strong. Regions on chromosomes 1, 6, 7, and 15 also showed linkage, with empirical P-values of less than 0.01 Of note, a pedigree containing 14 genotyped individuals and 10 affected individuals (nine definite and one probable) gave a KAC LOD of 1.2. However, the peak score for this pedigree was at 161 cM (closest to D3S1744) on chromosome 3q24, a different location from where the overall LOD score peaked (chr3q27-28). At this phase of our research, it is not possible to determine whether these peaks represent independent loci, an indication of genetic heterogeneity, or whether they are the consequence of insufficient statistical power, owing to insufficient map density. With the currently available genotype information, we cannot conclude with confidence whether these two peaks reflect evidence for one putative candidate gene or for two separate genes. Further genotyping with markers of higher density may lead to a clearer explanation for this observation.
We suspect that OCD is genetically heterogeneous. Our exploratory analysis showed that the inclusion of age of onset in a covariate-based linkage model might increase power to detect linkage by adjusting for heterogeneity. It is noteworthy that the LOD score calculated by LODPAL was 0.51 at D1S1679 when age of onset was not considered, but increased to 2.94 Figure 2 Results of covariate-based linkage analysis for 5 chromosomes. *The solid line represents the LOD score computed including covariates and the dotted line represents the LOD score computed without covariates using LODPAL. As described in the text, the differences between LOD score with/without covariates were noted for chromosome 1 and 7. Further stratification analysis showed that the signal on chromosome 1 was mostly contributed by families with younger age of onset and on chromosome 7, by later age of onset families.
when age of onset was included as a covariate. More importantly, the empirical P-value calculated for this signal was less than 0.001 using 1000 replicates. A similar increment in LOD score was observed on chromosome 7. Further, using stratification by age of onset of the proband, we were able to clarify whether the linkage information was contributed by the families with earlier or later age of onset. We recognize that the linkage signals on chromosome 1 and 7 are likely to be contributed by the families with earlier and later age of onset, respectively. However, we feel that more OCD families are needed to be genotyped to confirm these two observations. Therefore, these findings need to be interpreted with caution.
In the near future, we plan to further investigate each of the five suggestive linkage regions identified in this genome scan using a denser microsatellite panel (1 cM) and additional individuals. We also plan to conduct a more systematic evaluation of the role of serotonin receptors, which appear to play a major role in the pathogenesis of OCD. 32 Three candidate genes, the human 5-HT3 serotonin receptor-like genes HTR3C, 3D and 3E, located in the chromosome 3q27.1 region, are of particular interest since one of the markers with the highest LOD score, D3S1262, is 2.5 Mb downstream of these three genes. Also, the 5HTR3C gene is expressed in human brain cells where it encodes a subunit of the type 3 receptor for 5-hydroxytryptamine, a biogenic hormone that functions as a major neurotransmitter, and this receptor causes depolarizing responses in neurons after activation. 33 In addition to conducting fine mapping, the next phase of the OCD Collaborative Genetics Study will focus on covariate-based linkage analysis to identify potential sources of genetic heterogeneity. It is possible that one may find novel or stronger signals after including meaningful subphenotypes as covariates. In particular, we plan to include information such as hoarding status because, in the Hopkins OCD Family Study, we found that hoarding may cluster in families, 34 and our preliminary familial correlation analyses in OCGS families indicates that hoarding status is likely to be 'familial' (data not shown). We plan to perform a stratified analysis by subphenotypes such as hoarding status as well to perform covariate-based linkage analysis. 27 Further, future analyses will also seek to better account for phenotypic heterogeneity by using factor scores reflecting the various symptom dimensions of OCD. 35 Despite the reasonable size and well-characterized clinical definitions of OCD, this genome scan did not provide any 'significant linkage signals', according to guidelines proposed by Lander and Kruglyak 36 for the interpretation of linkage results. In a full genome scan with marker spacing less than 0.1 cM, the recommended P-value for a significant linkage finding is 0.000049 to achieve a genomewide significance level of 0.05. Lander and Kruglyak 36 also recommended that signals with uncorrected P-values less than 0.05 should be reported without a claim of linkage. Therefore, we can conclude only that this reasonably sized genome scans detected suggestive evidence for linkage, and that replication studies with similar or larger sample sizes are necessary.
Further, we note that, compared to other neuropsychiatric diseases, such as schizophrenia and bipolar disorder, OCD is a relative 'new-comer' to linkage studies. It is therefore extremely important to followup the positive findings reported from the current study. This strategy may be enhanced by increasing the sample size and marker density, developing novel statistical methods to identify sources of genetic heterogeneity, investigating the possibility of epistasis, and assessing the role of gene-environment interactions.
